skip to main content
Receive client alerts and/or Silicon Valley e-News in your inbox.
John Cox represents clients in patent litigation related to chemical, biotechnology, and pharmaceutical matters and has significant experience in Abbreviated New Drug Application (ANDA) cases.
John Cox counsels and represents clients in patent litigation related to chemical, biotechnology, medical device and pharmaceutical matters and has significant experience in Abbreviated New Drug Application (ANDA) cases, including pre-litigation investigations. Most recently, John was part of the team that successfully represented Ferring Pharmaceuticals Inc. and Ferring International Center S.A. in ANDA litigation regarding Ferring’s Prepopik® drug product. In that case, the Court issued an opinion that the proposed ANDA product infringed all asserted claims of the patents in suit. John is also lead counsel in litigation for Nutramax Laboratories involving patents covering Nutramax’s joint health supplements and provides pro bono counseling to The Neurobiology Foundation regarding their efforts to advance research into treatments, prevention, and cures for central nervous system disorders such as schizophrenia.
John has extensive experience related to discovery and motion practice, as well as developing both offensive and defensive strategies. He particularly enjoys dealing with complex subject matter and technical witnesses (inventors and experts), and counseling clients regarding litigation procedures and strategies. While John’s graduate research focused on the mechanism of action of anticancer agents, he has dealt with subject matter ranging from brain chemistry, the gastrointestinal system, and drug delivery systems, to medical diagnostic methods, the generation of biofuel using bacteria, and processes for manufacturing chemicals and pharmaceutical products.
John is currently barred in Georgia and licensed to practice before the United States Patent and Trademark Office. Early in his career, John drafted a portfolio of patent applications covering pharmaceutical subject matter and has advised clients regarding their patent prosecution strategies related to a variety of technologies. Given his knowledge of both patent litigation and patent prosecution, John enjoys counseling clients related to their world-wide intellectual property rights and strategies. As a part of that, John has worked with foreign pharmaceutical, chemical, and biotechnology companies throughout his career and developed expertise in navigating the crossroads of foreign business practices and the complexities of U.S. patent practice.
Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients.
Intellectual Property Litigation
Life Sciences Patent